A Study of TS-1, Cisplatin (CDDP) and RAD001 (Everolimus)
NCT01096199
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Interventions
DRUG:
TS-ONE, Cisplatin, RAD001
Sponsor
National University Hospital, Singapore